TMCI · Treace Medical Concepts, Inc. · Analyst Estimates
$4.03
-0.15 (-3.59%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$264.21M
Shares
65.56M
Volume · Nov 6
596.72K
Avg daily vol (3M)
274.2K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for Treace Medical Concepts, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-11-07 01:20 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.88
|
-0.85
|
-0.83
|
5
|
-0.85
|
-0.85
|
-0.90
|
-0.90
|
0
|
0
|
5
|
5
|
|
Revenue
USD
Publication date not stated |
206.40M
|
207.47M
|
208.00M
|
5
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.85
|
-0.85
|
-0.85
|
1
|
-0.90
|
-0.90
|
-0.90
|
-0.90
|
1
|
1
|
0
|
0
|
|
Revenue
USD
Publication date not stated |
218.40M
|
221.73M
|
227.10M
|
5
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.11
|
-0.11
|
-0.11
|
1
|
-0.09
|
-0.09
|
-0.09
|
-0.08
|
1
|
0
|
0
|
1
|
|
Revenue
USD
Publication date not stated |
66.50M
|
67.30M
|
68.00M
|
5
|
— | — | — | — | — | — | — | — |
Q ending 2027-03-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.27
|
-0.25
|
-0.22
|
2
|
-0.25
|
-0.25
|
-0.24
|
-0.24
|
0
|
0
|
2
|
2
|
|
Revenue
USD
Publication date not stated |
51.00M
|
51.50M
|
52.00M
|
2
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1630627
CUSIP
89455T109
13F (30d)
55 filings
43 filers
Visit website
Investor relations